Response to "Letter to Editor From Ishaq MU et al: 'Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease'"
J Endocr Soc. 2024 Dec 4;9(1):bvae218.
doi: 10.1210/jendso/bvae218.
eCollection 2024 Nov 26.
1 2nd Department of Internal Medicine Research Unit and Diabetes Centre Attikon Hospital Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
2 2nd Department of Cardiology Laboratory of Preventive Cardiology and Echocardiography Department Attikon Hospital Medical School, National and Kapodistrian University of Athens,12462 Athens, Greece.
3 3rd Department of Cardiology, National and Kapodistrian University of Athens, Medical School, Sotiria Chest Disease Hospital, 11527 Athens, Greece.
4 Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine, Attikon University Hospital, Joint Rheumatology Program, National and Kapodistrian University of Athens Medical School, 12462 Athens, Greece.
5 Clinical Research and Evidence-Based Medicine Unit, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.